CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 145 enrolled
Drug / intervention
Straumann Bone Level Implantdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00906425
NCT00906425N/ACompleted

Randomized, Controlled Clinical Study Comparing Submerged vs. Trans-mucosal Placement of P.004 Implants in the Anterior Maxilla and Mandible by Evaluation of the Change in Bone Level Between 1st Stage Surgery and 6 Months Post Surgery

Institut Straumann AG·interventional·Posted May 21, 2009·Updated Mar 30, 2016

In Brief

A clinical study evaluating Straumann Bone Level Implant for Jaw, Edentulous, Partially. Completed, enrolled 145 participants across 11 sites in 7 countries.

Detailed Summary

The purpose of this study is To demonstrate that there is no difference in change in bone level around P.004 implants between 1st stage surgery and 6 months post surgery when transmucosal implant placement is compared to submerged implant placement

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesAustralia, Germany, Italy, Spain, Sweden, Switzerland, United States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMay 21, 2009
Enrollment StartOct 1, 2006
Primary CompletionJun 1, 2008
Study CompletionOct 1, 2013
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 17.1 years ago

Interventions

Straumann Bone Level Implantdevice

Straumann Bone Level Implant, SLActive surface, diameter 4.1, length 8, 10, 12, and 14 mm